Multidrug-Resistant Tuberculosis in Patients with Human Immunodeficiency Virus. Management Considerations within High-resourced Settings.

Annals of the American Thoracic Society
John W WilsonSuzanne M Marks

Abstract

The management of multidrug-resistant tuberculosis (MDR TB) is notably complex among patients with human immunodeficiency virus (HIV). TB treatment recommendations typically include very little information specific to HIV and MDR TB, which often is derived from clinical trials conducted in low-resource settings. Mortality rates among patients with HIV and MDR TB remain high. We reviewed the published literature and recommendations to synthesize possible patient management approaches demonstrated to improve treatment outcomes in high-resourced countries for patients with MDR TB and HIV. Approaches to diagnostic testing, impact and timing of antiretroviral therapy on mortality, anti-MDR TB and antiretroviral drug interactions, and the potential role for short-course MDR TB therapy are examined. The combination of antiretroviral therapy with expanded TB drug therapy, along with the management of immune reconstitution inflammatory syndrome, other potential HIV-associated opportunistic diseases, and drug toxicities, necessitate an integrated multidisciplinary patient care approach using public health case management and provider expertise in drug-resistant TB and HIV management.

References

Feb 1, 1996·American Journal of Respiratory and Critical Care Medicine·M LutfeyB N Kreiswirth
May 9, 2003·The New England Journal of Medicine·Silvia G PrioriDonata Cappelletti
Jun 7, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jiehui LiJudith Sackoff
Jun 9, 2005·The Journal of Infectious Diseases·Guy E ThwaitesJeremy J Farrar
Aug 30, 2008·AIDS·Hugo López-GatellUNKNOWN Multicenter AIDS Cohort Study
Feb 26, 2010·The New England Journal of Medicine·Salim S Abdool KarimQuarraisha Abdool Karim
Apr 17, 2010·American Journal of Public Health·Lisa TrieuTiffany G Harris
May 6, 2010·American Journal of Respiratory and Critical Care Medicine·Armand Van DeunHans L Rieder
Sep 10, 2010·The New England Journal of Medicine·Catharina C BoehmeMark D Perkins
Oct 19, 2010·European Journal of Pharmacology·Shengna HanLirong Zhang
Feb 8, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Charlotte L KvasnovskyMartie L van der Walt
May 21, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M Estee TörökJeremy James Farrar
Oct 21, 2011·The New England Journal of Medicine·François-Xavier BlancUNKNOWN CAMELIA (ANRS 1295–CIPRA KH001) Study Team
Oct 21, 2011·The New England Journal of Medicine·Diane V HavlirUNKNOWN AIDS Clinical Trials Group Study A5221
Oct 21, 2011·The New England Journal of Medicine·Salim S Abdool KarimQuarraisha Abdool Karim
Jan 13, 2012·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·N R GandhiN S Shah
Apr 3, 2012·The European Respiratory Journal·G B MiglioriD Manissero
Nov 21, 2012·The Journal of Infectious Diseases·Neel R GandhiN Sarita Shah
Mar 5, 2013·The European Respiratory Journal·Francesco BlasiGiovanni Battista Migliori
Jun 12, 2013·Expert Review of Anti-infective Therapy·Ravindra K GargRajiv Garg
Jan 17, 2014·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·N PadayatchiG Friedland
Apr 23, 2014·Emerging Infectious Diseases·Suzanne M MarksUNKNOWN TB Epidemiologic Studies Consortium
May 23, 2014·Drugs·Abdullah Alsultan, Charles A Peloquin
Sep 14, 2014·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·K J M AungH L Rieder
Sep 14, 2014·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·A PiubelloA Van Deun
Apr 14, 2015·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·C KuabanA Trébucq
Apr 7, 2016·Journal of Acquired Immune Deficiency Syndromes : JAIDS·April C PettitUNKNOWN North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) investigators of International epidemiologic Dat
Aug 16, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Payam NahidAndrew Vernon
Jan 6, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David M LewinsohnGail L Woods
Jan 19, 2017·The New England Journal of Medicine·N Sarita ShahNeel R Gandhi

❮ Previous
Next ❯

Citations

Oct 22, 2020·NPJ Vaccines·Riti Sharan, Deepak Kaushal
Dec 15, 2020·Current Opinion in Infectious Diseases·David V MhangoHenry C Mwandumba

❮ Previous
Next ❯

Methods Mentioned

BETA
nucleic acid amplification
PCR

Software Mentioned

STRIDE

Related Concepts

Related Feeds

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

American Thoracic Association Journals

Discover the latest respiratory research published by the journals from the American Thoracic Society.